Related Experiment Video
Updated: Jun 10, 2026

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
Glucocorticoids potentiate IL-6-induced SP-B expression in H441 cells by enhancing the JAK-STAT signaling pathway
Andreas Ladenburger1, Matthias Seehase, Boris W Kramer
1Children's Hospital, Univ. of Würzburg, Germany.
Insights
Antenatal steroids and IL-6 synergistically boost surfactant protein B (SP-B) gene expression in lung cells, potentially explaining how prenatal treatments reduce respiratory distress syndrome (RDS) severity in preterm infants.
Area of Science:
- Pulmonary Medicine
- Neonatology
- Molecular Biology
- Cellular Signaling
Background:
- Respiratory distress syndrome (RDS) is a major cause of morbidity and mortality in preterm infants.
- Surfactant protein B (SP-B) deficiency is implicated in RDS pathogenesis.
- Antenatal corticosteroids and chorioamnionitis (inflammation) reduce RDS severity, involving IL-6 and JAK-STAT signaling.
Purpose of the Study:
- To investigate the synergistic effects of glucocorticoids (betamethasone/dexamethasone) and IL-6 on SP-B gene expression and STAT3 phosphorylation in H441 lung cells.
- To elucidate the molecular mechanisms underlying the protective effects of antenatal steroids and inflammation in RDS.
Main Methods:
- H441 lung cells were treated with betamethasone (BTM), dexamethasone (DXM), and/or IL-6.
- SP-B mRNA levels were quantified using RT-qPCR.
- STAT3 phosphorylation was assessed via Western blotting.
- JAK inhibitor was used to block signaling pathways.
- IL-6 receptor (IL-6R) expression was analyzed at mRNA and protein levels.
Main Results:
- Both DXM and BTM significantly increased SP-B mRNA levels.
- IL-6 alone also increased SP-B mRNA, but combined treatment with glucocorticoids and IL-6 resulted in a synergistic, greater increase.
- Glucocorticoids did not phosphorylate STAT3 but potentiated IL-6-induced STAT3 phosphorylation.
- This synergism was blocked by a JAK inhibitor, and glucocorticoids upregulated IL-6R expression.
Conclusions:
- Glucocorticoids and IL-6 exhibit a synergistic effect on SP-B gene expression in lung cells, mediated by the JAK-STAT pathway.
- Glucocorticoids enhance IL-6 signaling by upregulating the IL-6 receptor, providing a potential mechanism for their protective effects against RDS.
- These findings offer in vitro insights into how antenatal steroid administration combined with prenatal inflammation can mitigate RDS severity in preterm neonates.
Abstract:
The respiratory distress syndrome (RDS) contributes to perinatal morbidity and mortality associated with preterm birth. Surfactant protein B (SP-B) is decreased in RDS. Both maternal antenatal steroid administration and chorioamnionitis reduce the incidence and severity of RDS. An important mediator in chorioamnionitis is IL-6 using the JAK-STAT signaling pathway for signal transduction. We hypothesized that the steroids, betamethasone (BTM) and dexamethasone (DXM), and IL-6 had synergistic effects on SP-B gene expression and STAT3 phosphorylation in H441 cells. DXM and BTM increased SP-B mRNA levels by 16.5 (13.3)-fold and IL-6 alone by 2.3-fold. After 48-h exposure of cells to DXM or BTM, IL-6 caused a significantly greater increase in SP-B mRNA levels (28.1-fold) than IL-6 or glucocorticoids alone. Whereas IL-6 stimulated tyrosine phosphorylation of STAT3 in a time- and dose-dependent way, DXM and BTM had no effect on STAT3 phosphorylation. Both DXM and BTM could potentiate IL-6-induced phosphorylation of STAT3. The synergism of glucocorticoids and IL-6 on SP-B gene expression and the effect of glucocorticoids on IL-6-induced STAT3 phosphorylation could be blocked by a JAK inhibitor. Expression level analysis showed that glucocorticoids increased the expression of the IL-6-binding α-subunit receptor (IL-6R) on mRNA and protein level. Our findings could represent an example of a pulmonary regulation system in which one role of glucocorticoids is to increase the effect of a cytokine by upregulation of its receptor. The described in vitro interaction of IL-6 and glucocorticoids could help explain the clinical observation that prenatal inflammation in preterm babies with antenatal steroid administration can attenuate severity of RDS.
Related Concept Videos
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Two...
cAMP-dependent Protein Kinase Pathways
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...